This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
JD or EBAY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JD vs. EBAY: Which Stock Is the Better Value Option?
Zacks.com featured highlights include JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology
by Zacks Equity Research
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.
Are Retail-Wholesale Stocks Lagging JD.com (JD) This Year?
by Zacks Equity Research
Here is how JD.com, Inc. (JD) and LY Corporation Unsponsored ADR (YAHOY) have performed compared to their sector so far this year.
Should Value Investors Buy JD.com (JD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
A Key March Nonfarm Job Report is Coming
by John Blank
Will it show big DOGE Federal job cuts?
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
by Urmimala Biswas
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
Best Growth Stocks to Buy for March 28th
by Zacks Equity Research
COMM, DAN, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 28, 2025.
Zacks.com featured highlights JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys
by Zacks Equity Research
JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys have been highlighted in this Screen of The Week article.
3 Key Reasons to Buy JD.com Stock Beyond the 52.8% Surge in a Year
by Vasundhara Sawalka
JD's 52% surge, 8.58X P/E and global expansion make it a must-buy. With AI innovation and UEFA partnership, this e-commerce leader is set for 2025 growth.
JD.com (JD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JD.com (JD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?